• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine

Patent holdings for IPC class A61K 31/4375

Total number of patents in this class: 3884

10-year publication summary

223
298
267
270
296
303
323
376
333
118
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Deciphera Pharmaceuticals, LLC
245
72
Novartis AG
10327
58
Incyte Corporation
1060
51
F. Hoffmann-La Roche AG
7837
46
Immunomedics, Inc.
246
44
Merck Sharp & Dohme LLC
3729
43
Bristol-myers Squibb Company
4811
40
Merck Patent GmbH
5668
37
Hoffmann-La Roche Inc.
3699
36
Bayer Pharma AG
1026
36
Boehringer Ingelheim International GmbH
4509
35
Gilead Sciences, Inc.
2189
31
Bayer AG
3430
29
Shenzhen HighTide Biopharmaceutical, Ltd.
62
27
Pfizer Inc.
3367
26
Takeda Pharmaceutical Company Limited
2718
26
Janssen Pharmaceutica N.V.
3231
24
Genentech, Inc.
4076
23
Neurocrine Biosciences, Inc.
445
23
Pliant Therapeutics, Inc.
65
23
Other owners 3154